Avalo Therapeutics Statistics

Total Valuation

AVTX has a market cap or net worth of $131.10 million. The enterprise value is $50.86 million.

Market Cap	131.10M
Enterprise Value	50.86M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, before market open.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

AVTX has 9.68 million shares outstanding. The number of shares has increased by 1,461.15% in one year.

Shares Outstanding	9.68M
Shares Change (YoY)	+1,461.15%
Shares Change (QoQ)	+790.56%
Owned by Insiders (%)	1.15%
Owned by Institutions (%)	4.46%
Float	5.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.15
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	63.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.99

Current Ratio	0.99
Quick Ratio	0.97
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.08

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-20.94%
Return on Capital (ROIC)	-315.18%
Revenue Per Employee	$42,474
Profits Per Employee	-$1.91M
Employee Count	19
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, AVTX has paid $13,000 in taxes.

Income Tax	13,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.39% in the last 52 weeks. The beta is 1.03, so AVTX's price volatility has been similar to the market average.

Beta (5Y)	1.03
52-Week Price Change	-45.39%
50-Day Moving Average	10.04
200-Day Moving Average	9.99
Relative Strength Index (RSI)	64.92
Average Volume (20 Days)	35,254

Short Selling Information

The latest short interest is 49,242, so 0.51% of the outstanding shares have been sold short.

Short Interest	49,242
Short Previous Month	54,205
Short % of Shares Out	0.51%
Short % of Float	0.96%
Short Ratio (days to cover)	3.32

Income Statement

In the last 12 months, AVTX had revenue of $807,000 and -$36.22 million in losses. Loss per share was -$204.70.

Revenue	807,000
Gross Profit	-3.10M
Operating Income	-22.20M
Pretax Income	-142.87M
Net Income	-36.22M
EBITDA	-22.05M
EBIT	-22.20M
Loss Per Share	-$204.70

Full Income Statement

Balance Sheet

The company has $93.43 million in cash and $1.73 million in debt, giving a net cash position of $91.70 million or $9.47 per share.

Cash & Cash Equivalents	93.43M
Total Debt	1.73M
Net Cash	91.70M
Net Cash Per Share	$9.47
Equity (Book Value)	-2.15M
Book Value Per Share	-13.16
Working Capital	-503,000

Full Balance Sheet

Cash Flow

Operating Cash Flow	-32.09M
Capital Expenditures	n/a
Free Cash Flow	-32.09M
FCF Per Share	-$3.31

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,751.05%
Pretax Margin	-4,486.99%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-1,850.34%

Dividends & Yields

AVTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,461.15%
Shareholder Yield	-1,461.15%
Earnings Yield	-27.63%
FCF Yield	-24.48%

Analyst Forecast

The average price target for AVTX is $35.00, which is 158.49% higher than the current price. The consensus rating is "Buy".

Price Target	$35.00
Price Target Difference	158.49%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 29, 2023. It was a reverse split with a ratio of 0.0041667:1.

Last Split Date	Dec 29, 2023
Split Type	Reverse
Split Ratio	0.0041667:1

Scores

AVTX has an Altman Z-Score of -5.25 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.25
Piotroski F-Score	2